19:35 , Aug 31, 2018 |  BC Week In Review  |  Financial News

China GL Capital claims 5% stake in U.K.'s Oxford BioDynamics

Epigenetic biomarker company Oxford BioDynamics plc (LSE:OBD) partnered with GL Capital Group to address demand for healthcare and personalized medicine in China. The Greater China healthcare-focused firm will act as the U.K.-based biotech's lead mainland...
18:44 , Aug 31, 2018 |  BC Week In Review  |  Financial News

China Biologic spurns acquisition proposal, seeks $590M raise

Plasma products company China Biologic Products Holdings Inc. (NASDAQ:CBPO) said it turned down an acquisition proposal made on Aug. 17, and said it is raising $590 million in a private placement. The Aug. 17 proposal...
20:15 , Aug 24, 2018 |  BC Extra  |  Company News

China Biologic spurns acquisition proposal, seeks $590M raise

Plasma products company China Biologic Products Holdings Inc. (NASDAQ:CBPO) said it turned down an acquisition proposal made last week, and said it is raising $590 million in a private placement. The Aug. 17 proposal to...
22:12 , Aug 22, 2018 |  BC Extra  |  Financial News

China's GL Capital claims 5% stake in U.K.'s Oxford BioDynamics

Epigenetic biomarker company Oxford BioDynamics plc (LSE:OBD) partnered with GL Capital Group to address demand for healthcare and personalized medicine in China. The Greater China healthcare-focused firm will act as the U.K.-based biotech's lead mainland...
21:07 , Aug 20, 2018 |  BC Extra  |  Company News

Consortium including Gao, GL Capital bid to take China Biologic private

A consortium comprising former executive David Gao, GL Capital Group, Bank of China Group Investment Ltd. and CDH Investments proposed on Friday to take plasma products company China Biologic Products Holdings Inc. (NASDAQ:CBPO) private for...